
doi: 10.1002/jps.24324
This paper assesses the current regulatory environment, relevant regulations and guidelines, and their impact on continuous manufacturing. It summarizes current regulatory experience and learning from both review and inspection perspectives. It outlines key regulatory aspects, including continuous manufacturing process description and control strategy in regulatory files, process validation, and key Good Manufacturing Practice (GMP) requirements. In addition, the paper identifies regulatory gaps and challenges and proposes a way forward to facilitate implementation.
Quality Control, Drug Industry, United States Food and Drug Administration, Guidelines as Topic, Legislation, Drug, United States, Workflow, Europe, Pharmaceutical Preparations, Consumer Product Safety, Equipment Contamination, Humans, Technology, Pharmaceutical, Equipment Failure, Patient Safety, Drug Contamination
Quality Control, Drug Industry, United States Food and Drug Administration, Guidelines as Topic, Legislation, Drug, United States, Workflow, Europe, Pharmaceutical Preparations, Consumer Product Safety, Equipment Contamination, Humans, Technology, Pharmaceutical, Equipment Failure, Patient Safety, Drug Contamination
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 154 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
